Original Research
Published on 19 Nov 2025
Cost-utility analysis of PCSK9 inhibitors for hypercholesterolemia: a Chinese healthcare perspective
in Drugs Outcomes Research and Policies
- 289 views
Original Research
Published on 19 Nov 2025
in Drugs Outcomes Research and Policies
Systematic Review
Published on 19 Nov 2025
in Drugs Outcomes Research and Policies
Original Research
Published on 19 Nov 2025
in Drugs Outcomes Research and Policies
Editorial
Published on 19 Nov 2025
in Drugs Outcomes Research and Policies
Original Research
Accepted on 18 Nov 2025
in Drugs Outcomes Research and Policies
Review
Published on 18 Nov 2025
in Drugs Outcomes Research and Policies
Original Research
Published on 18 Nov 2025
in Drugs Outcomes Research and Policies
Original Research
Accepted on 17 Nov 2025
in Drugs Outcomes Research and Policies
Original Research
Accepted on 17 Nov 2025
in Drugs Outcomes Research and Policies
Original Research
Accepted on 17 Nov 2025
in Drugs Outcomes Research and Policies
Original Research
Accepted on 17 Nov 2025
in Drugs Outcomes Research and Policies
Systematic Review
Accepted on 14 Nov 2025
in Drugs Outcomes Research and Policies
Original Research
Accepted on 14 Nov 2025
in Drugs Outcomes Research and Policies
Original Research
Accepted on 14 Nov 2025
in Drugs Outcomes Research and Policies
Original Research
Published on 13 Nov 2025
in Drugs Outcomes Research and Policies
Original Research
Published on 13 Nov 2025
in Drugs Outcomes Research and Policies